Veracyte CCO John Leite Sells 4,015 Shares

What Happened
John Leite, Veracyte’s Global Chief Commercial Officer, sold 4,015 shares of Veracyte (VCYT) in an open-market transaction on September 21, 2026. The shares were sold at $40.00 per share for total proceeds of $160,600. This was a sale (S) and not a purchase; sales by insiders are often routine and can be pre-planned.

Key Details

• Transaction date: 2026-09-21; Filing date: 2026-09-22 (filed promptly)
• Transaction type: Sale (S) — open market/private sale reported
• Price and amount: 4,015 shares at $40.00 each; proceeds = $160,600
• Footnote: Transaction executed pursuant to a Rule 10b5-1 trading plan adopted June 9, 2026
• Shares owned after transaction: Not specified in the Form 4 filing

Context
A 10b5-1 plan allows insiders to execute pre-arranged trades at predetermined times and is commonly used to avoid questions about timing or intent. Because this sale was made under such a plan and was filed quickly (next business day), it generally appears to be a planned disposition rather than an ad hoc insider signal.